In patients with HF, all-cause mortality, MACE, and stroke trended in favor of dronedarone prescription but did not reach statistical significance.
← all excerpts
Pharmacologic rhythm control for atrial fibrillation with dronedarone versus sotalol in patients with and without heart failure.
1
—
—